Literature DB >> 15262108

Antimalarial combinations.

Peter Gottfried Kremsner1, Sanjeev Krishna.   

Abstract

Multidrug resistance has rendered monotherapy for malaria useless in most parts of the world, and has also compromised the usefulness of many of the available combination chemotherapies. New antimalarial regimens are, therefore, urgently needed. We review the various antimalarial combinations that can be used to treat otherwise drug-resistant disease, and discuss what defines an ideal antimalarial combination regimen.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15262108     DOI: 10.1016/S0140-6736(04)16680-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  75 in total

1.  Medical research at the Albert Schweitzer Hospital.

Authors:  Saadou Issifou; Ayola A Adegnika; Bertrand Lell
Journal:  Wien Klin Wochenschr       Date:  2010-03       Impact factor: 1.704

2.  Tropical medicine at the University of Tübingen.

Authors:  Peter Gottfried Kremsner
Journal:  Wien Klin Wochenschr       Date:  2010-03       Impact factor: 1.704

3.  Efficacy and safety of a new pediatric artesunate-mefloquine drug formulation for the treatment of uncomplicated falciparum malaria in Gabon.

Authors:  Marielle K Bouyou-Akotet; Michael Ramharter; Edgard Brice Ngoungou; Modeste Mabika Mamfoumbi; Mireille Pemba Mihindou; Michel A Missinou; Florian Kurth; Sabine Bélard; Selidji T Agnandji; Saadou Issifou; János L Heidecker; Sonja Trapp; Peter G Kremsner; Maryvonne Kombila
Journal:  Wien Klin Wochenschr       Date:  2010-03       Impact factor: 1.704

4.  In vitro and in vivo interactions between miltefosine and other antileishmanial drugs.

Authors:  Karin Seifert; Simon L Croft
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

5.  Randomized controlled trial of fosmidomycin-clindamycin versus sulfadoxine-pyrimethamine in the treatment of Plasmodium falciparum malaria.

Authors:  Sunny Oyakhirome; Saadou Issifou; Peter Pongratz; Fortune Barondi; Michael Ramharter; Jürgen F Kun; Michel A Missinou; Bertrand Lell; Peter G Kremsner
Journal:  Antimicrob Agents Chemother       Date:  2007-02-26       Impact factor: 5.191

6.  The fight against malaria -- this month in Vienna.

Authors:  Christiane Druml; Peter Gottfried Kremsner
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

7.  Treatment of malaria in Austria: hazardous for patients or physicians?

Authors:  Sabine Bélard; Florian Kurth; Stefan Winkler; Wolfgang Graninger; Michael Ramharter
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

8.  Measuring resistant-genotype transmission of malaria parasites: challenges and prospects.

Authors:  Rashad Abdul-Ghani; Hoda F Farag; Amal F Allam; Ahmed A Azazy
Journal:  Parasitol Res       Date:  2014-02-22       Impact factor: 2.289

9.  Water-soluble polymer-drug conjugates for combination chemotherapy against visceral leishmaniasis.

Authors:  Salvatore Nicoletti; Karin Seifert; Ian H Gilbert
Journal:  Bioorg Med Chem       Date:  2010-03-02       Impact factor: 3.641

10.  Tolerability and efficacy of a pediatric granule formulation of artesunate-mefloquine in young children from Cameroon with uncomplicated falciparum malaria.

Authors:  Félix Tietche; David Chelo; Njiki Kinkela Mina Ntoto; Florence Minjiwa Djoukoue; Christoph Hatz; Sarabel Frey; Adrian Frentzel; Sonja Trapp; Roland Zielonka; Edgar A Mueller
Journal:  Am J Trop Med Hyg       Date:  2010-06       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.